Since April, biotech startup GrayBug has made several important moves, the first being one of three winners in the state’s inaugural InvestMaryland Challenge and winning $100,000 from the state’s venture fund as a result.
On top of closing a recent round of nearly $1.5 million in venture funding, as Technical.ly Baltimore noted in late October, GrayBug recently hired its first full-time CEO, Michael O’Rourke, according to the Baltimore Business Journal.
GrayBug, which develops drug delivery tech for treating macular degeneration, a leading cause of vision loss in Americans over 60 years in age, was spun out of the Johns Hopkins University Wilmer Eye Institute.
Johns Hopkins spinout GrayBug hires first full-time CEO
On top of closing a recent round of nearly $1.5 million in venture funding, Michael O’Rourke joins as the biotech startup’s first CEO.
